about
Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia.Non-MHC-restricted cytotoxic cells: their roles in the control and treatment of leukaemias.Immunological weapons against acute myeloid leukaemia.Immunotherapy in multiple myeloma--possibility or probability?Interferon-α in acute myeloid leukemia: an old drug revisited.Remission maintenance in acute myeloid leukemia: impact of functional histamine H2 receptors expressed by leukemic cells.Treatment of relapse after allogeneic bone marrow transplantation with reduced intensity conditioning (FLAG +/- Ida) and second allogeneic stem cell transplant.
P2860
Q33881750-495606C9-E5C3-41A5-94E5-D73AAFFE849AQ34319345-F0A69F58-3F39-4ECF-BC9E-67AE6761C703Q34842175-BDE83163-970A-4AFD-A6FD-104AA1E59B16Q36206601-BD971CEC-4EC9-4342-B320-E503A0305E99Q37832939-C41EDDE8-B551-41C5-B2ED-4A9A582E3B9EQ41527981-6361FD39-718C-4ED7-A2E4-4D0D4851BF51Q43817807-47579921-4D4A-4CF7-859F-306C0CA20F5A
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Immunotherapy of AML: future directions
@ast
Immunotherapy of AML: future directions
@en
type
label
Immunotherapy of AML: future directions
@ast
Immunotherapy of AML: future directions
@en
prefLabel
Immunotherapy of AML: future directions
@ast
Immunotherapy of AML: future directions
@en
P2860
P356
P1476
Immunotherapy of AML: future directions
@en
P2093
P2860
P356
10.1136/JCP.53.1.49
P407
P577
2000-01-01T00:00:00Z